We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome - a case report and discussion.
- Authors
Myakova, Natalia; Smirnova, Nadezhda; Evstratov, Dmitry; Abugova, Yulia; Balashov, Dmitry; Diakonova, Yulia; Konovalov, Dmitry; Skvortsova, Yulia; Maschan, Alexey
- Abstract
Key Clinical Message Treatment of patients with refractory Hodgkin lymphoma is a significant issue. We report a patient with Proteus syndrome and relapsed Hodgkin lymphoma, whose remission was finally achieved after brentuximab vedotin therapy, allowing her to receive a haploidentical stem cell transplant. The possible relationship between both disorders was discussed.
- Subjects
HODGKIN'S disease treatment; ANTIBODY-drug conjugates; PROTEUS syndrome; MUSCULOSKELETAL system abnormalities; STEM cell transplantation; THERAPEUTICS
- Publication
Clinical Case Reports, 2015, Vol 3, Issue 7, p646
- ISSN
2050-0904
- Publication type
Article
- DOI
10.1002/ccr3.297